Join
Live feed
·
PRReleasevia Quantisnow
Anteris Technologies Global Corp. logo

FDA Approves Anteris's DurAVR® THV Global Pivotal Trial (the "PARADIGM Trial")

ByQuantisnow·Wall Street's wire, on your screen.
AVR· Anteris Technologies Global Corp.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AVR (Anteris Technologies Global Corp.) and more on Quantisnow.